Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C)

•Persons with opioid use disorder can be recruited, enrolled, and retained in rigorous trials.•Individual, site, and state level practices and policies can facilitate rigorous trial conduct.•Hepatitis C virus infection is an excellent use case for evaluation of virtual healthcare delivery and expansion of access to specialty medical care for medically underserved populations.•Integration of medical and behavioral treatment facilitates rigorous trial conduct.